In 2024, successful biotech product launches require strategic planning, data-driven marketing, understanding of regulatory landscape, key partnerships, and post-launch adaptation. A course, ‘Mastering the Biotech Product Launch’, targets biotech professionals and covers product development, launch strategies, and offers certification upon completion, with a duration of 6-8 hours.
The future of pharma M&A in 2024 is marked by consolidation, focusing on biotech and specialty drugs, increased cross-border activity, and emphasis on digital and data capabilities. Drivers include technological advancements and market expansion, while challenges involve regulatory complexities and cultural integration. The sector anticipates continued growth with a focus on collaboration and innovation.
Skyrizi leads top 10 pharma brands with 3.1 billion impressions and a record $45.6 million national TV ad expenditure.
Sanofi unveils 12 potential blockbusters amid shareholder unease over the wait for their market realization.
Takeda secures licensing for Hutchmed’s Fruzaqla with a $1.1 billion deal, bolstering its portfolio with this promising Chinese pharmaceutical innovation.
Explore the latest in medical marketing, key personnel shifts, and buzzing industry conversations in this week’s insightful update.
Botanical Solutions innovates with a sustainable QS-21 production platform from Quillaja saponaria, enhancing vaccine adjuvants in Latin America.
Explore the latest in medical marketing, key personnel shifts, and buzzing industry conversations in this week’s insightful update.
Explore the latest in medical marketing, key personnel shifts, and buzzing industry conversations in this week’s insightful update.
Roche acquires Carmot’s GLP-1 assets along with a robust portfolio of clinical and preclinical research and development projects.
Signup our newsletter to get update information, product or insight.
Bio Data Studio is a cloud-based data tool brought to you by ARSENAL ADVISORS, the leading life science commercialization agency.
